These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32954463)

  • 1. What is the impact of patient recruitment on offshoring of clinical trials?
    Kermanimojarad M
    Life Sci Soc Policy; 2020 Sep; 16(1):10. PubMed ID: 32954463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonconsensual clinical trials: a foreseeable risk of offshoring under global corporatism.
    Spielman B
    J Bioeth Inq; 2015 Mar; 12(1):101-6. PubMed ID: 25630592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Speed of Enrollment for Clinical Trials Conducted by Japanese and Global Pharmaceutical Companies.
    Maeda H; Yamanoi M; Fukuda Y; Inaba Y
    Biol Pharm Bull; 2023; 46(9):1289-1295. PubMed ID: 37661408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory challenges in the review of data from global clinical trials: the PMDA perspective.
    Asano K; Tanaka A; Sato T; Uyama Y
    Clin Pharmacol Ther; 2013 Aug; 94(2):195-8. PubMed ID: 23872835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
    Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
    Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint recommendations for a total services account as a factor in simplifying contracts.
    Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
    Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond offshoring: assess your company's global potential.
    Farrell D
    Harv Bus Rev; 2004 Dec; 82(12):82-90, 148. PubMed ID: 15605568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globalization and the pharmaceutical industry revisited.
    Busfield J
    Int J Health Serv; 2003; 33(3):581-605. PubMed ID: 14582874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importancia de la investigación clínica independiente en la medicina: dificultades y recomendaciones.
    Arrieta O; Campillo C; Burgos R; Celis MÁ; Llata M; Domínguez J; Halabe J; Islas S; Jasso L; Lifshitz A; Moreno M; Plancarte R; Reyes-Sánchez A; Ruiz-Argüelles GJ; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2019; 155(3):319-321. PubMed ID: 31219475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
    Shi YZ; Hu H; Wang C
    Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug development and the heart hospital.
    Kleiman JH
    Am Heart Hosp J; 2003; 1(2):188-91. PubMed ID: 15815142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data monitoring and interim analyses in the pharmaceutical industry: ethical and logistical considerations.
    Rockhold FW; Enas GG
    Stat Med; 1993 Mar; 12(5-6):471-9. PubMed ID: 8493425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving clinical study efficiency by using a productivity breakdown model: comparative evaluation of a global clinical study and a similar Japanese study.
    Takahashi K; Sengoku S; Kimura H
    J Clin Pharm Ther; 2011 Feb; 36(1):87-98. PubMed ID: 21198723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator.
    Idänpään-Heikkilä JE
    Ann Med; 1994 Apr; 26(2):89-94. PubMed ID: 8024733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators.
    Barratt MJ; Potter GR; Wouters M; Wilkins C; Werse B; Perälä J; Pedersen MM; Nguyen H; Malm A; Lenton S; Korf D; Klein A; Heyde J; Hakkarainen P; Frank VA; Decorte T; Bouchard M; Blok T
    Int J Drug Policy; 2015 Mar; 26(3):238-49. PubMed ID: 25576247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic imperatives for globalization of industries in developing countries: an Indian pharmaceutical industry example.
    Srivastava R; Chandra A; Kumar G
    Health Mark Q; 2004; 22(1):57-69. PubMed ID: 15914384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notable deals in the pharmaceutical industry in the first quarter of 2017.
    Cruces E
    Drugs Today (Barc); 2017 Jun; 53(6):357-365. PubMed ID: 28799581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.